Indo US Bio-Tech
INDOUS • Agricultural Food & other Products
Last Price
₹79.34
Market Cap
₹159.09 Cr
Sector
Agricultural Food & other Products
For educational/research use only. Not a recommendation to buy or sell.
At a glance
as of 2026-09-17Sector: Indo US Bio-Tech (INDOUS) is an NSE-listed company in the Agricultural Food & other Products sector, within the Other Agricultural Products industry.
Sharia screening: Indo US Bio-Tech is rated Halal by the specialist provider whose screen we publish.
47% below its 52-week high
Price trend
Strongly negative
Over the last 6 months, Indo US Bio-Tech's share price has fallen, doing better than 7% of Agricultural Food & other Products stocks.
Institutional activity
Neutral
Trading patterns over recent weeks show no clear sign of institutions buying or selling Indo US Bio-Tech (buying score 3/10, selling score 2/10).
Model rank
Negative
Our model's 5-day return score puts Indo US Bio-Tech ahead of 34% of NSE stocks. The model has low confidence in this score (32%).
Ease of trading
Elevated
Some signs that trading in Indo US Bio-Tech is thinner than usual (risk score 6/10). Volume has been below normal for 6 days.
Price vs profits
Below typical
The share price is 12× last year's profit per share — below the typical range for NSE stocks (15–30×).
The wider Indian market is in a downtrend (model 100% sure). This affects every stock's model rank.
Browse ready-made screens →Company Information
About Indo US Bio-Tech (INDOUS)
Indo US Bio-Tech is an NSE-listed company operating in the Agricultural Food & other Products sector, within the Other Agricultural Products industry (ISIN INE250Z01010). This page brings together the quantitative research signals our models compute for INDOUS: a model-estimated 1-day, 5-day and 21-day return outlook, momentum and trend indicators, institutional-activity context derived from observed trading flows, a snapshot of valuation and quality fundamentals, and the instrument's Sharia-compliance status. All figures are produced by statistical models from historical data and are intended for research and educational purposes.
To read the page, treat the model-estimated return outlook as a relative ranking signal rather than a forecast of price — higher scores reflect stronger model-estimated momentum and trend alignment, not a target or guarantee. The momentum and trend indicators describe how Indo US Bio-Tech's recent price action compares with its own history, while the fundamentals and institutional-activity context add longer-horizon and flow-based perspective. Nothing here is investment advice, a recommendation, or a solicitation to transact; always do your own research and consult a SEBI-registered adviser before making any decision.
The "typical range" we compare a price-to-earnings multiple against is a fixed band for all NSE stocks, not a sector-specific one. Everything on this page describes what our models measured; none of it is a recommendation to do anything.